PerpEquities

IDEXX Laboratories, Inc. (IDXX) balance sheet

NASDAQ · Healthcare · Medical - Diagnostics & Research · 11,000 employees · CEO Michael Erickson

Price
$698.55 +3.94%
Market cap
$55B
Enterprise value
$55.8B
Last report
Q3 '26 filed 2026-11-02
Next report
2027-02-01 EPS est. $3.33

At the end of Q3 '26 IDEXX Laboratories, Inc. (IDXX) held $198M in cash and short-term investments against $973M of debt incl. leases. Total assets $3.71B, total liabilities $1.84B, shareholders' equity $1.87B.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$454M$397M$402M$309M$288M$164M$165M$208M$180M$201M$197M$198M
Receivables$530M$578M$608M$587M$561M$604M$663M$715M$693M$697M$742M$616M
Inventory$380M$391M$380M$390M$382M$396M$393M$392M$378M$382M$392M$391M
Other current assets$83.1M$88.1M$92.3M$91M$110M$100M$95.5M$31.5M$31.3M$110M$117M$229M
Current assets$1.5B$1.5B$1.53B$1.43B$1.4B$1.32B$1.36B$1.41B$1.34B$1.45B$1.51B$1.5B
Property, plant & equipment (net)$818M$829M$828M$839M$829M$834M$869M$868M$871M$862M$856M$852M
Long-term investments$56.2M$54.4M$53.8M$55.2M$57.7M$58M$58.3M$277M$297M$53.6M$53.9M$29M
Goodwill$366M$409M$408M$412M$405M$407M$414M$414M$414M$412M$411M$641M
Intangible assets$84.5M$115M$111M$107M$112M$107M$104M$115M$110M$105M$98.2M$118M
Deferred tax assets$107M$107M$126M$135M$126M$123M$125M$31.5M$27.9M$23.3M$22.7M$26.1M
Other non-current assets$333M$338M$360M$369M$364M$366M$397M$275M$291M$476M$491M$542M
Non-current assets$1.76B$1.85B$1.89B$1.92B$1.89B$1.9B$1.97B$1.98B$2.01B$1.93B$1.93B$2.21B
Total assets$3.26B$3.35B$3.41B$3.35B$3.29B$3.21B$3.33B$3.39B$3.35B$3.39B$3.44B$3.71B
Liabilities
Accounts payable$111M$117M$117M$111M$114M$120M$117M$122M$110M$130M$129M$154M
Accrued expenses$198M$206M$251M$251M$244M$244M$175M$180M$212M$202M$192M$408M
Short-term debt$325M$325M$420M$349M$418M$490M$654M$605M$500M$680M$669M$549M
Taxes payable$86.6M$134M$146M$80.1M$62.3M$102M$75.2M$0$0$0$0$86.6M
Deferred revenue$37.2M$38.2M$38M$38.4M$33.8M$35M$36.3M$35.7M$35.3M$36.3M$36.4M$40.2M
Other current liabilities$174M$116M$124M$159M$175M$122M$141M$193M$202M$145M$158M$86.6M
Current liabilities$952M$957M$1.12B$1.01B$1.07B$1.14B$1.22B$1.25B$1.15B$1.3B$1.29B$1.26B
Long-term debt$623M$621M$525M$525M$450M$450M$450M$375M$476M$300M$300M$300M
Lease obligations (non-current)$99.7M$104M$103M$103M$97.8M$97M$108M$106M$101M$98.7M$101M$97.5M
Deferred revenue (non-current)$28.5M$28M$26.8M$26.8M$26.9M$26.8M$31.8M$31.1M$32.2M$32.3M$32.6M$32.7M
Deferred tax liabilities$7.24M$8.75M$10M$5.66M$11.3M$8.11M$2.09M$3.72M$31.9M$44.6M$52.6M$61.2M
Other non-current liabilities$65.5M$66.3M$53.4M$62.9M$44.3M$47.7M$56.8M$57.6M-$44.6M$54M$56.5M$82.4M
Non-current liabilities$824M$828M$718M$723M$630M$629M$648M$574M$597M$530M$542M$574M
Total liabilities$1.78B$1.78B$1.83B$1.73B$1.7B$1.77B$1.87B$1.83B$1.75B$1.83B$1.83B$1.84B
Equity
Common stock & paid-in capital$10.8M$10.8M$10.8M$10.8M$10.8M$10.8M$10.8M$10.8M$10.8M$10.9M$10.9M$10.9M
Retained earnings$4.44B$4.68B$4.88B$5.12B$5.33B$5.58B$5.87B$6.14B$6.39B$6.67B$7.01B$7.33B
Accumulated other comprehensive income-$71.2M-$80.4M-$85.2M-$76M-$93.6M-$90.1M-$77M-$66.7M-$68.8M-$64.9M-$63.5M-$60.5M
Shareholders' equity$1.48B$1.57B$1.58B$1.62B$1.6B$1.45B$1.46B$1.56B$1.61B$1.56B$1.61B$1.87B
Debt
Total debt (incl. leases)$1.07B$1.07B$1.07B$998M$987M$1.06B$1.24B$1.11B$1.08B$1.11B$1.1B$973M
Net debt (debt - cash)$613M$672M$666M$690M$699M$895M$1.07B$905M$897M$905M$899M$775M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30

Data as of 2026-11-05